Results 21 to 30 of about 1,107 (189)

Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone [PDF]

open access: yesFrontiers in Pharmacology, 2023
Regardless of the clinical impact of human adenovirus (HAdV) infections in the healthy population and its high morbidity in immunosuppressed patients, a specific treatment is still not yet available.
María Balsera-Manzanero   +12 more
doaj   +2 more sources

Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis [PDF]

open access: yesCell Death and Disease
Radioresistance is a major constraint on the efficacy of lung cancer radiotherapy, but its mechanism has not been fully elucidated. Here, we found that FBXO22 was aberrantly highly expressed in lung cancer and that FBXO22 knockdown increased the ...
Yunshang Chen   +12 more
doaj   +2 more sources

Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation [PDF]

open access: yesCell Death and Disease
Cutaneous squamous carcinoma is the second most common epithelial malignancy, associated with significant morbidity, mortality, and economic burden. However, the mechanisms underlying cSCC remain poorly understood.
Kaili Zhou   +10 more
doaj   +2 more sources

Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells

open access: yesInternational Journal of Hematology, 2009
The aim of the study was to investigate the anticancer effects and the molecular mechanisms of deguelin on Jurkat cells. Cell viability was assessed by MTT assay.
Shu, W-X   +4 more
core   +5 more sources

Effect of deguelin on expression of nup98 in K562 cells

open access: yesZhongguo shi yan xue ye xue za zhi, 2007
The study was purposed to investigate the effect of deguelin on expression of nucleoporin 98 (nup98) in leukemia K562 cells. MTT assay was used to assess the effects of deguelin on cell proliferation.
Chen, WH, Wu, QL, Chen, Y, He, J
core   +2 more sources

BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells. [PDF]

open access: yesPLoS ONE, 2016
This study has been undertaken to explore the therapeutic effects of deguelin and specific siRNAs in HeLa cells. The data provided clearly show the silencing of ERK 1/2 with siRNAs and inhibition of ERK1/2 with deguelin treatment in HeLa cells ...
Samra Hafeez   +15 more
doaj   +1 more source

Amelioration of an undesired action of deguelin [PDF]

open access: yesToxicon, 2013
The pharmaceutical world has greatly benefited from the well-characterized structure-function relationships of toxins with endogenous biomolecules, such as ion-channels, receptors, and signaling molecules. Thus, therapeutics derived from toxins have been aggressively pursued.
Julie A, Vrana   +3 more
openaire   +2 more sources

Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model. [PDF]

open access: yesPLoS ONE, 2016
B-cell chronic lymphocytic leukemia (CLL) remains an incurable disease, and despite the improvement achieved by therapeutic regimes developed over the last years still a subset of patients face a rather poor prognosis and will eventually relapse and ...
Nerea Rebolleda   +9 more
doaj   +1 more source

Mitochondrial DNA mutations in ageing and cancer

open access: yesMolecular Oncology, Volume 16, Issue 18, Page 3276-3294, September 2022., 2022
Mitochondrial DNA mutations are a common feature of ageing tissues and a number of human cancers. They can affect essential mitochondrial functions such as oxidative phosphorylation, redox balance, apoptosis, and numerous biosynthetic pathways. These are important mechanisms which reportedly impact tumour growth, though data are often contradictory ...
Anna L. M. Smith   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy